Alzheimer's disease, a progressive neurodegenerative disorder, currently lacks a cure but several medications aim to alleviate symptoms and slow progression. Cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, enhance communication among brain cells by preserving acetylcholine, a neurotransmitter crucial for memory and learning. Another class, NMDA receptor antagonists like memantine, regulates glutamate activity to mitigate symptoms like confusion and memory loss. Emerging research explores potential treatments targeting amyloid plaques and tau tangles, hallmark brain abnormalities in Alzheimer's. These include monoclonal antibodies like aducanumab, designed to clear amyloid plaques, and tau-targeting therapies. While these treatments offer hope, ongoing research aims to better understand Alzheimer's complex mechanisms to develop more effective therapies.
Jun Hua
Johns Hopkins University , United States
Nazneen N Dewji
Cenna Biosciences Inc, United States
Jacqueline London
Paris Diderot University, FranceSubmit your abstract Today
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Make a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Health care professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Somali Red Crescent Society, Somalia
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States